StonvexLoading…
StonvexStonvexStonvexCore line items from VYNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $570.00K | $501.00K | $424.00K | $477.00K |
Operating Income | $-29.75M | $-43.64M | $-29.26M | $-34.30M |
Net Income | $-26.48M | $-39.83M | $-28.45M | $-23.21M |
EPS (Diluted) | $-0.62 | $-0.93 | $-2.78 | $-7.28 |
Total Assets | $30.16M | $66.91M | $97.69M | $40.76M |
Total Liabilities | $2.40M | $14.82M | $8.95M | $9.35M |
Cash & Equivalents | $24.03M | $19.93M | $30.62M | $30.91M |
Free Cash Flow OCF − CapEx | $-33.12M | $-34.09M | $-25.34M | Not available |
Shares Outstanding | 33.32M | 14.83M | 14.10M | 3.23M |